
Wet AMD
Latest News
Advertisement
Video Series
Shorts

0:49
Can AXPAXLI serve as a foundational therapy to improve durability in wet AMD?
2 months ago
by
Arshad M. Khanani, MD, MA, FASRS(+2 more)

0:41
AXPAXLI's real-world potential to reduce wet AMD treatment gaps
3 months ago
by
Arshad M. Khanani, MD, MA, FASRS(+2 more)

1:00
AXPAXLI shows superiority in SOL-1 wet AMD trial
3 months ago
by
Arshad M. Khanani, MD, MA, FASRS(+2 more)
CME Content
Advertisement
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Brepocitinib meets all Phase 3 end points in noninfectious uveitis
2
Myopia control using spectacle lenses with highly aspherical lenslets
3
Demodex blepharitis: Diagnosis, treatment response, and recurrence
4
CHMP recommends ranibizumab biosimilar Fovlussea for retinal disease
5















